184

Technology&AI
Sub Categories on Technology&AI
{{items.name}}
Latest Articles
Weekly Update of Drug News-4/9/2025

Weekly Update of Drug News-4/9/2025

On Aug 21, 2025, Abbvie announced that positive results from study 1 of the Phase 3 UP-AA clinical program evaluating the safety and efficacy of RINVOQ® (Upadacitinib) in adult and adolescent patients with severe alopecia areata (AA) with a mean baseline
Updated on: September 04,2025 0
Weekly Update of Drug News-4/9/2025

Weekly Update of Drug News-4/9/2025

On Aug 21, 2025, Abbvie announced that positive results from study 1 of the Phase 3 UP-AA clinical program evaluating the safety and efficacy of RINVOQ® (Upadacitinib) in adult and adolescent patients with severe alopecia areata (AA) with a mean baseline
Updated on:September 04,2025 0
Smarter Lungs: How Genetic Algorithms Are Revolutionizing AI in Pulmonary Medicine

Smarter Lungs: How Genetic Algorithms Are Revolutionizing AI in Pulmonary Medicine

Lung diseases represent a critical global health concern. Lung cancer continues to be the leading cause of cancer-related death, while the burden of chronic obstructive pulmonary disease (COPD) and long-term pulmonary complications from COVID-19 further s
Updated on: August 14,2025 0
Smarter Lungs: How Genetic Algorithms Are Revolutionizing AI in Pulmonary Medicine

Smarter Lungs: How Genetic Algorithms Are Revolutionizing AI in Pulmonary Medicine

Lung diseases represent a critical global health concern. Lung cancer continues to be the leading cause of cancer-related death, while the burden of chronic obstructive pulmonary disease (COPD) and long-term pulmonary complications from COVID-19 further s
Updated on:August 14,2025 0
A Window to the Womb: Leveraging AI and Retinal Vascular Imaging for Early, Non-Invasive Diagnosis of Preeclampsia

A Window to the Womb: Leveraging AI and Retinal Vascular Imaging for Early, Non-Invasive Diagnosis of Preeclampsia

Preeclampsia is a leading cause of maternal and fetal morbidity and mortality, affecting 2–8% of pregnancies globally. Each year, it accounts for approximately 46,000 maternal and over 500,000 fetal deaths, disproportionately burdening low-resource settin
Updated on: July 25,2025 0
A Window to the Womb: Leveraging AI and Retinal Vascular Imaging for Early, Non-Invasive Diagnosis of Preeclampsia

A Window to the Womb: Leveraging AI and Retinal Vascular Imaging for Early, Non-Invasive Diagnosis of Preeclampsia

Preeclampsia is a leading cause of maternal and fetal morbidity and mortality, affecting 2–8% of pregnancies globally. Each year, it accounts for approximately 46,000 maternal and over 500,000 fetal deaths, disproportionately burdening low-resource settin
Updated on:July 25,2025 0
More News
Categories
Anesthesiology & Pain
Cardiology & Vascular surgery
Dermatology
Diabetes & Endocrinology
ENT & HN Surgery
Emergency Medicine & ICU
Epidemiology & Public Health
Family Medicine
Gastroenterology
Geriatrics
Hepatobiliary & Pancreas Surgery
Immunology & Rheumatology
Nephrology & Urology
Neurology
Nutrition
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedics & Sports medicine
Pediatrics
Psychiatry
Pulmonology
Reproduction
Stomatology
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Medicine.net
WMO.com
Sleep.net
Nutrition.net